We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Gene Poses Neurologic Risk to Infants after Heart Surgery

By HospiMedica staff writers
Posted on 04 Feb 2004
A study has found that children with heart conditions requiring surgery are more at risk of neurologic problems if they have a particular version of a gene. More...
The finding was reported in the December 2003 issue of the Journal of Thoracic and Cardiovascular Surgery.

Researchers evaluated 244 children at age one who had undergone surgery to repair a congenital heart defect at less than six months of age. Specifically, they found that children carrying the epsilon2 version (APOE 2) of the apolipoprotein E gene were significantly more apt to have worse neurodevelopmental outcomes at age one, compared to children who also had surgery but lacked that version of the gene. The epsilon2 version occurs in about 8% of the population. This variant may decrease the ability of neurons to repair themselves following open heart surgery, so that children score lower in developmental evaluations of psychomotor skills. The link between the gene variant and lower neurodevelopmental scores was consistent, even after researchers controlled for variables such as gestational age, age at surgery, socioeconomic status, type of cardiac defect, and surgical techniques.

"The adverse effect on neurodevelopment that we found at one year of age does not necessarily predict long-term outcome for these children,” cautioned study leader J. William Gaynor, M.D., a cardiothoracic surgeon at The Children's Hospital of Philadelphia (PA, USA). "Children will need to be evaluated as they reach school age to determine whether the APOE 2 gene is a risk factor for worse long-term outcome.”




Related Links:
Children's Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.